...
首页> 外文期刊>Radiology >Risk of Upgrade of Atypical Ductal Hyperplasia after Stereotactic Breast Biopsy: Effects of Number of Foci and Complete Removaln of Calcifications
【24h】

Risk of Upgrade of Atypical Ductal Hyperplasia after Stereotactic Breast Biopsy: Effects of Number of Foci and Complete Removaln of Calcifications

机译:立体定向乳腺活检后非典型性导管增生的升级风险:病灶数目和钙化完全清除的影响

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To determine if patients with fewer than three foci of atypical ductal hyperplasia (ADH) who have all of their calcifications removed after stereotactic 9- or 11-gauge vacuum-assisted breast biopsy (VABB) have a rate of upgrade to malignancy that is sufficiently low to obviate surgical excision. Materials and Methods: An institutional review board–approved, HIPAA-compliant retrospective review of 991 cases of consecutive 9- or 11-gauge stereotactic VABB performed during a 65-month period revealed 147 cases of atypia. One pathologist performed a blinded review of the results of procedures performed to assess for calcifications and confirmed ADH in 101 cases with subsequent surgical excision. Each large duct or terminal duct–lobular unit containing ADH was considered a focus and counted. Postbiopsy mammograms were reviewed to determine whether all calcifications were removed. Upgrade to malignancy was determined from excisional biopsy pathology reports. Upgrade rates as a function of both number of foci and presence or absence of residual calcifications were calculated and compared by using χ2 tests. Results: Upgrade to malignancy occurred in 20 (19.8%) of the 101 cases. The upgrade rate was significantly higher in cases of three or more foci of ADH (15 [28%] of 53 cases) than in cases of fewer than three foci (five [10%] of 48 cases) (P = .02). Upgrade rates were similar, regardless of whether all mammographic calcifications were removed (seven [17%] of 41 cases) or all were not removed (nine [20%] of 45 cases) (P = .77). Upgrade occurred in two (12%) of 17 cases in which there were fewer than three ADH foci and all calcifications were removed. Conclusion: The upgrade rate is significantly higher when ADH involves at least three foci. Surgical excision is recommended even when ADH involves fewer than three foci and all mammographic calcifications have been removed, because the upgrade rate is 12%. © RSNA, 2010
机译:目的:确定在立体定向9或11规格真空辅助乳腺活检(VABB)后,所有钙化均已去除的少于三个非典型导管增生(ADH)病灶的患者,其恶性程度是否提高到足够低以免手术切除。材料和方法:经过机构审查委员会批准的HIPAA符合性回顾性研究,对在65个月内进行的991例连续9或11规格立体定向VABB患者进行回顾性研究。一名病理学家对101例患者进行了手术评估,以评估其钙化程度并确认了ADH,并对其结果进行了盲法检查。每个包含ADH的大导管或终末导管小叶单位均视为焦点并计数。复查活检后的乳房X光照片以确定是否去除了所有钙化。根据切除活检病理报告确定是否恶变。通过χ 2 检验,计算并评价了转化率随病灶数量和是否存在残留钙化的变化,并进行了比较。结果:101例病例中有20例(19.8%)发生了恶变。在三个或三个以上ADH灶的病例中(53例中的15例[28%]),其升级率明显高于三个以下灶(48例中的5例[10%])(P = .02)。无论是否移除了所有乳房X光检查钙化(41例中的七个[17%])或未移除所有乳腺X射线摄影的钙化(45例中的九个[20%]),升息率均相似(P = .77)。 17例中有2例(12%)发生升级,其中ADH灶少于3个,并且所有钙化均被清除。结论:ADH至少涉及三个病灶时,升级率明显更高。即使ADH的病灶少于三个灶且所有乳腺X射线钙化均已去除,仍建议手术切除,因为升级率是12%。 ©RSNA,2010年

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号